![]()
|
|
||||||||
J. Biol. Chem., Vol. 264, Issue 36, 21450-21453, 12, 1989
JL Treadway, BD Morrison, ID Goldfine and JE Pessin
Insulin and Mn/MgATP treatment of immunoaffinity-purified alpha beta
heterodimeric insulin receptors induced the formation of an alpha 2 beta 2
heterotetrameric insulin receptor complex. In contrast, insulin- like
growth factor-1 (IGF-1) treatment was completely ineffective in inducing
the association of alpha beta heterodimeric insulin receptors. Similarly,
IGF-1 or Mn/MgATP, but not insulin, treatment of immunoaffinity-purified
alpha beta heterodimeric IGF-1 receptors induced the formation of an alpha
2 beta 2 heterotetrameric IGF-1 receptor complex. A monoclonal antibody
specific for the insulin receptor (MA5) completely immunoprecipitated all
the insulin binding activity from both the alpha 2 beta 2 heterotetrameric
and alpha beta heterodimeric insulin receptor complexes but did not
immunoprecipitate IGF-1 receptors. Conversely, the IGF-1 receptor-specific
monoclonal antibody (alpha IR-3) immunoprecipitated all the IGF-1 binding
activity, but not insulin receptors. The simultaneous treatment of pooled
equal amounts of alpha beta heterodimeric insulin and IGF-1 receptors with
a combination of insulin and IGF-1 resulted in the formation of alpha 2
beta 2 heterotetrameric insulin and IGF-1 receptor complexes. However, in
the mixed alpha 2 beta 2 heterotetrameric receptor fraction MA5
immunoprecipitated 94% of the insulin binding in addition to 27% of the
IGF-1 binding activity whereas alpha IR-3 immunoprecipitated 97% of the
IGF-1 binding in addition to 38% of the insulin binding activity. Treatment
of the mixed alpha beta heterodimeric insulin and IGF-1 receptors with
Mn/MgATP also resulted in the formation of cross-immunoreactive (42-46%)
alpha 2 beta 2 heterotetrameric receptors. These data directly demonstrate
the formation of insulin/IGF-1 hybrid receptors by both a combination of
insulin plus IGF-1 or Mn/MgATP treatment of purified human placenta alpha
beta heterodimeric insulin and IGF-1 half-receptors in vitro.
Assembly of insulin/insulin-like growth factor-1 hybrid receptors in vitro
Department of Physiology and Biophysics, University of Iowa, Iowa City 52242.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. A. Kiely, A. Sant, and R. O'Connor RACK1 Is an Insulin-like Growth Factor 1 (IGF-1) Receptor-interacting Protein That Can Regulate IGF-1-mediated Akt Activation and Protection from Cell Death J. Biol. Chem., June 14, 2002; 277(25): 22581 - 22589. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spampinato, G. Pandini, A. Iuppa, V. Trischitta, R. Vigneri, and L. Frittitta Insulin/Insulin-Like Growth Factor I Hybrid Receptors Overexpression Is Not an Early Defect in Insulin-Resistant Subjects J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4219 - 4223. [Abstract] [Full Text] |
||||
![]() |
M. Federici, O. Porzio, D. Lauro, P. Borboni, B. Giovannone, L. Zucaro, M. L. Hribal, and G. Sesti Increased Abundance of Insulin/Insulin-Like Growth Factor-I Hybrid Receptors in Skeletal Muscle of Obese Subjects Is Correlated with In Vivo Insulin Sensitivity J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2911 - 2915. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |